UnicoCell Biomed CO. LTD   Report issue

For profit Phase 2 Phase 3
Founded: Taipei Taiwan (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2016
NCT02784964
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

UnicoCell Biomed CO. LTD